Superoxide radical production stimulates retroocular fibroblast proliferation in graves' ophthalmopathy

Henry B. Burch, Sabita Lahiri, Rebecca S. Bahn, Susan Barnes

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Retroocular fibroblast proliferation is believed to be a key component in the pathogenesis of Graves' ophthalmopathy. In the present study, we assessed the ability of superoxide radicals, generated using the xanthine oxidase/hypoxanthine system to induce cellular proliferation in cultured human retroocular fibroblasts obtained from two patients with severe Graves' ophthalmopathy and two control patients undergoing corrective eye surgery. In tissue obtained from patients with Graves' ophthalmopathy, fibroblast proliferation, as assessed by [3H]-thymidine incorporation, was induced by superoxide radicals in a dose-dependent manner. Xanthine oxidase or hypoxanthine alone had no proliferative effect, and control retroocular fibroblasts showed no proliferation in response to superoxide generation. Preincubation with the antithyroid drug methimazole, at concentrations ranging from 0-25 μM, prevented superoxide-induced fibroblast proliferation in a dose-response pattern. Preincubation with the xanthine oxidase inhibitor, allopurinol (1.0 mM) or the antioxidant nicotinamide (10 μM) also inhibited superoxide-induced fibroblast proliferation, whereas propylthiouracil (10 μM) had little effect. These studies suggest a pathway through which oxygen free radicals may contribute to the retroocular fibroblast proliferation observed in patients with Graves' ophthalmopathy.

Original languageEnglish (US)
Pages (from-to)311-316
Number of pages6
JournalExperimental Eye Research
Volume65
Issue number2
DOIs
StatePublished - Aug 1997

Fingerprint

Graves Ophthalmopathy
Superoxides
Fibroblasts
Xanthine Oxidase
Methimazole
Antithyroid Agents
Propylthiouracil
Allopurinol
Niacinamide
Thymidine
Free Radicals
Reactive Oxygen Species
Antioxidants
Cell Proliferation

Keywords

  • Autoimmunity
  • Cigarette smoking
  • Graves' disease
  • Ophthalmopathy
  • Oxidative damage
  • Pathogenesis
  • Retroocular fibroblast
  • Superoxide dismutase
  • Superoxide radical
  • Thyroid

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems

Cite this

Superoxide radical production stimulates retroocular fibroblast proliferation in graves' ophthalmopathy. / Burch, Henry B.; Lahiri, Sabita; Bahn, Rebecca S.; Barnes, Susan.

In: Experimental Eye Research, Vol. 65, No. 2, 08.1997, p. 311-316.

Research output: Contribution to journalArticle

Burch, Henry B. ; Lahiri, Sabita ; Bahn, Rebecca S. ; Barnes, Susan. / Superoxide radical production stimulates retroocular fibroblast proliferation in graves' ophthalmopathy. In: Experimental Eye Research. 1997 ; Vol. 65, No. 2. pp. 311-316.
@article{d79efe3513d245d78db218903fa02dbf,
title = "Superoxide radical production stimulates retroocular fibroblast proliferation in graves' ophthalmopathy",
abstract = "Retroocular fibroblast proliferation is believed to be a key component in the pathogenesis of Graves' ophthalmopathy. In the present study, we assessed the ability of superoxide radicals, generated using the xanthine oxidase/hypoxanthine system to induce cellular proliferation in cultured human retroocular fibroblasts obtained from two patients with severe Graves' ophthalmopathy and two control patients undergoing corrective eye surgery. In tissue obtained from patients with Graves' ophthalmopathy, fibroblast proliferation, as assessed by [3H]-thymidine incorporation, was induced by superoxide radicals in a dose-dependent manner. Xanthine oxidase or hypoxanthine alone had no proliferative effect, and control retroocular fibroblasts showed no proliferation in response to superoxide generation. Preincubation with the antithyroid drug methimazole, at concentrations ranging from 0-25 μM, prevented superoxide-induced fibroblast proliferation in a dose-response pattern. Preincubation with the xanthine oxidase inhibitor, allopurinol (1.0 mM) or the antioxidant nicotinamide (10 μM) also inhibited superoxide-induced fibroblast proliferation, whereas propylthiouracil (10 μM) had little effect. These studies suggest a pathway through which oxygen free radicals may contribute to the retroocular fibroblast proliferation observed in patients with Graves' ophthalmopathy.",
keywords = "Autoimmunity, Cigarette smoking, Graves' disease, Ophthalmopathy, Oxidative damage, Pathogenesis, Retroocular fibroblast, Superoxide dismutase, Superoxide radical, Thyroid",
author = "Burch, {Henry B.} and Sabita Lahiri and Bahn, {Rebecca S.} and Susan Barnes",
year = "1997",
month = "8",
doi = "10.1006/exer.1997.0353",
language = "English (US)",
volume = "65",
pages = "311--316",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Superoxide radical production stimulates retroocular fibroblast proliferation in graves' ophthalmopathy

AU - Burch, Henry B.

AU - Lahiri, Sabita

AU - Bahn, Rebecca S.

AU - Barnes, Susan

PY - 1997/8

Y1 - 1997/8

N2 - Retroocular fibroblast proliferation is believed to be a key component in the pathogenesis of Graves' ophthalmopathy. In the present study, we assessed the ability of superoxide radicals, generated using the xanthine oxidase/hypoxanthine system to induce cellular proliferation in cultured human retroocular fibroblasts obtained from two patients with severe Graves' ophthalmopathy and two control patients undergoing corrective eye surgery. In tissue obtained from patients with Graves' ophthalmopathy, fibroblast proliferation, as assessed by [3H]-thymidine incorporation, was induced by superoxide radicals in a dose-dependent manner. Xanthine oxidase or hypoxanthine alone had no proliferative effect, and control retroocular fibroblasts showed no proliferation in response to superoxide generation. Preincubation with the antithyroid drug methimazole, at concentrations ranging from 0-25 μM, prevented superoxide-induced fibroblast proliferation in a dose-response pattern. Preincubation with the xanthine oxidase inhibitor, allopurinol (1.0 mM) or the antioxidant nicotinamide (10 μM) also inhibited superoxide-induced fibroblast proliferation, whereas propylthiouracil (10 μM) had little effect. These studies suggest a pathway through which oxygen free radicals may contribute to the retroocular fibroblast proliferation observed in patients with Graves' ophthalmopathy.

AB - Retroocular fibroblast proliferation is believed to be a key component in the pathogenesis of Graves' ophthalmopathy. In the present study, we assessed the ability of superoxide radicals, generated using the xanthine oxidase/hypoxanthine system to induce cellular proliferation in cultured human retroocular fibroblasts obtained from two patients with severe Graves' ophthalmopathy and two control patients undergoing corrective eye surgery. In tissue obtained from patients with Graves' ophthalmopathy, fibroblast proliferation, as assessed by [3H]-thymidine incorporation, was induced by superoxide radicals in a dose-dependent manner. Xanthine oxidase or hypoxanthine alone had no proliferative effect, and control retroocular fibroblasts showed no proliferation in response to superoxide generation. Preincubation with the antithyroid drug methimazole, at concentrations ranging from 0-25 μM, prevented superoxide-induced fibroblast proliferation in a dose-response pattern. Preincubation with the xanthine oxidase inhibitor, allopurinol (1.0 mM) or the antioxidant nicotinamide (10 μM) also inhibited superoxide-induced fibroblast proliferation, whereas propylthiouracil (10 μM) had little effect. These studies suggest a pathway through which oxygen free radicals may contribute to the retroocular fibroblast proliferation observed in patients with Graves' ophthalmopathy.

KW - Autoimmunity

KW - Cigarette smoking

KW - Graves' disease

KW - Ophthalmopathy

KW - Oxidative damage

KW - Pathogenesis

KW - Retroocular fibroblast

KW - Superoxide dismutase

KW - Superoxide radical

KW - Thyroid

UR - http://www.scopus.com/inward/record.url?scp=0030872121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030872121&partnerID=8YFLogxK

U2 - 10.1006/exer.1997.0353

DO - 10.1006/exer.1997.0353

M3 - Article

C2 - 9268599

AN - SCOPUS:0030872121

VL - 65

SP - 311

EP - 316

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 2

ER -